valganciclovir and Leukemia--T-Cell

valganciclovir has been researched along with Leukemia--T-Cell* in 1 studies

Other Studies

1 other study(ies) available for valganciclovir and Leukemia--T-Cell

ArticleYear
[Typhlitis: report of a case and review of the literature].
    La Revue de medecine interne, 2008, Volume: 29, Issue:3

    Typhlitis is a rare condition, characterized by necrotizing inflammation of the colon. It occurs mainly in neutropenic patients receiving chemotherapy for leukemia.. We report the case of a 64-year-old woman with T-cell lymphocytic leukaemia, who exhibited asymptomatic reactivation of cytomegalovirus infection and developed subsequently typhlitis.. The pathological mechanisms of typhlitis remain unclear in neutropenic patients. The role of cytotoxic drugs as well as both bacterial overgrowth and translocation has been postulated. In our patient, asymptomatic reactivation of cytomegalovirus infection may have increased chemotherapeutic-agents-digestive toxicity.

    Topics: Alemtuzumab; Anti-Bacterial Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antineoplastic Agents; Antiviral Agents; Bacterial Translocation; Cytomegalovirus Infections; Enterocolitis, Neutropenic; Female; Ganciclovir; Humans; Leukemia, T-Cell; Middle Aged; Radiography, Abdominal; Tomography, X-Ray Computed; Typhlitis; Valganciclovir

2008